INTRODUCTION 67
Asthma is a chronic disease of the conducting airways that is characterized by airways 68 inflammation, airways remodeling, and progressive loss of lung function. It is increasingly 69 recognized as a highly heterogeneous disorder comprising multiple sub-phenotypes (1). The 70 atopic form of the disease develops in early childhood, and is initiated by sensitization to 71 inhalant allergens exemplified by house dust mite (HDM). Progression of atopic asthma 72 towards chronicity is driven by repeated cycles of airways inflammation, in particular severe 73 exacerbations triggered by respiratory infections which involve interactions between host 74 anti-viral and atopy-associated effector mechanisms (2, 3), and the rate of the ensuing 75 decline in lung function is related to the frequency and intensity of these exacerbations (4-76 6). 77
78
Recent clinical intervention studies, including those demonstrating that treatment with anti-79 IgE reduces exacerbation frequency, confirms the causal role of Th2 responses in these 80 intermittent events (7-9). However the degree to which chronic exposure to Th2-stimulatory 81 perennial aeroallergens contributes to the inflammatory milieu in the airway mucosa of 82 sensitized atopics during the periods between overt exacerbation events, thus potentially 83 influencing long-term persistence of the asthma-associated wheezy phenotype, remains 84 unclear. This is an important issue in relation to design of future therapeutic strategies for 85 prevention of asthma progression i.e. is it sufficient to target severe exacerbation events 86 alone, or is it potentially necessary to also dampen ongoing aeroallergen-driven Th2 87 reactivity at baseline in sensitized/perennially exposed subjects? 88
We have addressed this issue in a study population consisting of 22yr olds from an 90 unselected birth cohort resident in Perth Western Australia (10). We have previously shown 91 that the dominant asthma-associated aeroallergen in this region is HDM (11) which is 92 present in local households at high levels throughout the year (12), and accordingly the 93 study focused primarily on atopics who were sensitized and chronically exposed to HDM. 94 Our approach was based on the recent demonstration that induced sputum, which contains 95 a sample of cell populations present on the airway surface, can potentially be used for gene 96 expression profiling of wheeze-associated inflammatory responses in asthmatics (13, 14) . 97
98
In the present investigation we have employed RNA-Seq in conjunction with coexpression 99 network analysis to profile asthma-associated gene networks in sputum samples collected at 100 (symptom-free) baseline from study groups matched for age, HDM sensitization status and 101 environmental exposure, but dichotomous with respect to wheezing symptom expression. 102
Our findings suggest that upregulation of Th2 signature genes exemplified by the effector 103 cytokines IL-5 and IL-13 is a common feature across the whole HDM S /exposed population at 104 baseline, but in the subgroup with history of current wheeze the Th2 signature is more 105 complex and intense, and is uniquely networked with a series of concomitantly upregulated 106 epithelial cell associated pathways. 107 Cohort (Raine study, (10, 11)). The 22-year follow-up included 1234 active participants. 114
Subjects were selected for case/control studies based on their clinical characteristics and the 115 availability of high quality sputum samples (see below). Four clinical groups were defined; (i) 116 HDM sensitized atopics (SPT ≥ 3.0mm) with current wheeze during previous 12mths, with or 117 without a physician diagnosis of "asthma ever" (HDM S wheezers, n=16); (ii) HDM sensitized 118 atopics without current asthma or wheeze (HDM S nonwheezers, n=24); (iii) nonatopics with 119 current asthma and/or wheeze (nonatopic wheezers, n=7); (iv) nonatopics without current 120 asthma or wheeze (nonatopic controls, n=21). 121 122
Sputum induction and processing 123
Induced sputum was obtained after mannitol inhalation challenge (15). The samples were 124 stored at 4 C for up to 2 hours prior to processing. Sputum was processed (see the online 125 data supplement) by selection and subsequent disruption of mucus plugs with forceps to 126 minimize contamination with saliva (16 
RNA-Seq data analysis 138
The quality of the RNA-Seq data was assessed with the Bioconductor package Rqc (see Fig.  139 E1 in the online data supplement). Reads were aligned to the reference genome (hg19) 140 using Subread, and summarized at the gene-level using featureCounts (17). Genes with less 141 than 300 total counts were removed from the analysis. Differentially expressed genes were 142 identified employing Empirical analysis of digital gene expression data in R (EdgeR) with 143
False Discovery Rate (FDR) control for multiple testing (18). The analysis was adjusted for 144 latent variation using the Remove Unwanted Variation (RUV) algorithm ( Fig. E2 (19) ). Primary bronchial epithelial cells were obtained from 8 healthy nonatopic children and 8 159 atopic asthmatic children with HDM allergy who were undergoing elective surgery for non-160 respiratory related conditions. Cytospins were prepared and stained for CDHR3 and DAPI 161 using methods previously described (see online supplementary methods). 162 163 164
RESULTS 165
The characteristics of the 4 study groups are illustrated in Table 1 
170
The cellular composition of sputum from these subjects was dominated by macrophages 171 and neutrophils, which constituted 88-94% of the overall population, and the proportion of 172 these cell types (and overall total yields) did not differ between the groups (see 173 supplementary Table E1 ). Squamous cells and lymphocytes comprised on average 4.5% and 174 1.8% respectively and also did not differ between groups. Small numbers of eosinophils 175 were detectable only in the atopic groups and were highest in the wheezers (Table E1) . 176 177 Gene expression patterns in sputum were firstly compared between HDM S nonwheezers 178 and nonatopic controls. The data showed that 80 genes were upregulated (including the Th2 179 signature genes IL-5 [4.15 logfold] and IL-13 [2.92 logfold]) and 11 genes were 180 downregulated (FDR < 0.05, Table E2 ). To obtain detailed information on the regulatory 181 interactions between these genes, we utilized experimentally supported findings from 182 published studies (prior knowledge) to reconstruct the underlying network (20). This 183 analysis showed that the genes were mainly involved in IL-1B and IL-5/IL-13 signaling (Fig 1) . 184
Secondly, comparing gene expression patterns between HDM S wheezers and nonatopic 186 controls showed that 842 genes were upregulated (again including IL-5 [5.29 logfold], IL-13 187 [3.03 logfold] and IL-33 [2.59 logfold]) and 11 genes were downregulated in the wheezers 188 (FDR < 0.05, Table E3 ). As illustrated in Fig. 2 , the prior knowledge network revealed that 189 these genes revolved around a few hubs -erb-b2 receptor tyrosine kinase 2 (ERBB2/HER2), 190 which was involved in 59 interactions (also known as 'edges' in graph theory (23)), IL-13 (44 191 edges), and E-Cadherin/CDH1 (37 edges). 192 193 Thirdly, we compared gene expression patterns between HDM S wheezers versus HDM S 194 nonwheezers. The data showed that 859 genes were upregulated and 8 genes were 195 downregulated (FDR < 0.05, Table E4 ). The prior knowledge network constructed from these 196 genes ( Fig. 3 ) identified epidermal growth factor receptor (EGFR, 60 edges), ERBB2 (56 197 edges) and CDH1 (38 edges) as hub genes. It is noteworthy that IL-13 did not feature here 198 since it was not differentially expressed after adjustment for multiple testing (p-value = 199 0.028, FDR = 0.27). In contrast, IL-33 was upregulated in this comparison (2.74 logfold; Table  200 E4). 201 202 Finally, we compared gene expression in nonatopic wheezers with nonatopic controls, and a 203 single gene -LIM domain binding 3 (LDB3), was upregulated in the subjects with wheeze 204 (FDR = 2.6 x 10 -5 ). As expected, there was no evidence of a Th2 signature. 205 206 It has been reported that hub genes in biological interaction networks often exhibit limited 207 expression changes in experimental asthma models (24), thus a potential caveat of the 208 above analyses, which focused on differentially expressed genes, is that some hubs may 209 have escaped detection. To address this issue, we constructed a genome-wide coexpression 210 network, utilizing the data from both atopic groups (n=40). The resulting network comprised 211 14,833 genes organized into 23 coexpression modules. To identify disease-associated 212 modules, we plotted the -Log10 p-values derived from the above differential expression 213 analyses on a module-by-module basis. The data showed that the modules were not 214 different between HDM S nonwheezers and nonatopic controls ( Fig E5A) . In contrast, three 215 modules (designated A, P, and Q) were upregulated in HDM S wheezers versus the other two 216 groups (nonatopic controls, HDM S nonwheezers, Fig E5B, E5C) . 217 218 Module "P" contained 319 genes, and the prior knowledge network constructed from these 219 genes contained the hub genes EGFR (35 edges) and CDH1 (31 edges, Fig E6) . Module "Q" 220 contained 440 genes, and the hubs in the resultant prior knowledge network were ERBB2 221 (35 edges) and IL-13 (27 edges, Fig E7) . Principal component analysis showed that these two 222 modules (P, Q) were highly correlated (Pearson correlation: 0.897, P-value = 4.441 x 10 -15 ) 223 ( Fig E8) , suggesting they are subunits of a larger parent module. Therefore, we merged them 224 into a single network. In the merged network the dominant hubs were EGFR (73 edges), 225 ERBB2 (65 edges), CDH1 (56 edges) and IL-13 (48 edges, Fig E9) . Notably, these hubs connect 226 to both common and unique pathways (Fig 4) . The biological function of the genes that 227 interact with the hubs was interrogated using Gene Ontology terms (Table E5 ) and Pubmed 228 searches (Table E6) . Module "A" contained 506 genes. It was not possible to reconstruct 229 this module using prior knowledge, because no interactions were found for the vast majority 230 of genes. Therefore we used unbiased correlation patterns to reconstruct the network (21). 231
This analysis showed that the highest-ranking coexpression hubs were TEKT1, FOXJ1, 232 ARMC3, PIFO, DNAH5, RSPH1, FAM81B, SNTN, CDHR3, ERICH3, DNAH9, and CAPSL ( Fig 5) . 233
This module was strongly enriched with genes involved in the function of ciliated epithelial 234 cells (Table E7) . 235
236
We selected CDHR3 for further study because our data suggests it is a hub that functions in 237 ciliated epithelial cells, and a previous study reported it was a susceptibility gene for severe 238 asthma exacerbations (25). CDHR3 expression was examined in bronchial epithelial cells 239 from HDM sensitized children with asthma (n=8) and from nonatopic controls (n=8) using 240 immunostaining (see Table E7 for subject characteristics). The data showed there was 241 positive staining localized to the apical surface of columnar epithelial cells in both cohorts 242 ( Fig. 6A, Fig E10) . Of particular interest was the observation that expression of CDHR3 243 (green) appeared more intense and defined in airway epithelial cells derived from the 244 asthmatic children, and this was confirmed by image quantification (Fig. 6B) . 245 246 247
DISCUSSION 248
An increasing body of epidemiological and experimental evidence (reviewed (2, 3, 26)), now 249 supported by a range of intervention studies (4-6), argues for a causal role for Th2-250 associated inflammatory mechanisms in the aetiology and pathogenesis of atopic asthma. 251
However the precise details of the underlying causal pathways still remain incompletely 252 understood. In particular, the relative contributions of airways inflammation resulting from 253 acute severe exacerbation events versus chronic exposure to relevant aeroallergens to time-254 related lung function decline in asthmatics, remains unknown. Moreover, while it is 255 undisputed that sensitization to perennial aeroallergens is an important asthma risk factor, 256 community wide studies clearly demonstrate that only a minority of sensitized subjects 257 (including of those highly sensitized to HDM (11)) ever develop persistent wheeze. This 258 suggests that additional cofactor(s) may be required to unmask the full pathogenic potential 259 of aeroallergen-specific sensitization. A likely candidate in this regard is the airway 260 epithelium which may function as both a target for Th2-associated inflammation and/or as 261 an active participant via production of a range of immunomodulatory molecules that can 262 regulate the local functioning of Th2 cells and also Th2 cytokine-secreting group 2 innate 263 lymphoid cells (7-9). 264 265 Our current study design represents an unbiased approach towards testing this possibility. 266
In the core experiments we have sampled induced sputum cell populations from 267 equivalently sensitized adult atopics undergoing natural aeroallergen exposure, and 268 subsequent gene expression profiling and ensuing bioinformatics analyses after stratification 269 on the basis of wheezing phenotypes provides novel insight into the nature of the 270 inflammatory processes ongoing on the airway mucosal surface at the time of sampling. 271
272
Our initial analyses showed that a Th2 gene expression program was upregulated in baseline 273 sputum samples from the HDM sensitized atopics, regardless of whether these subjects 274 have current history of wheeze. The key Th2 genes IL-5 and IL-13 were upregulated to 275 comparable degrees in both groups, however in HDM S nonwheezers the overall Th2 276 program was restricted to only a small number of IL-5/IL-13-associated genes. In contrast, 277 hundreds of genes were upregulated in HDM S wheezers and network analysis suggested 278 that these genes function in the context of two discrete coexpression modules. 279
Reconstruction of the first module using prior knowledge revealed that the hub genes EGFR, 280 ERBB2, CDH1, and IL-13 dominated the network structure. The second coexpression module 281 comprised genes that control mucociliary clearance, and reconstruction of this module 282 employing unbiased gene coexpression patterns identified CDHR3 as a hub. Overall, our 283 findings suggest that the molecular mechanisms that determine susceptibility to asthma-284 associated wheeze amongst HDM sensitized atopics involve complex interactions between 285
Th2 and epithelial gene networks. that blocking ERBB2 signaling in vitro attenuated neuregulin-induced upregulation of 310 MUC5AC and MUC5B (33). Notably, our network analysis showed that ERBB2 connects to 311 anterior gradient 2 (AGR2). Previous studies have shown that ERBB2 upregulates the 312 transcription and secretion of AGR2 (34, 35). AGR2 binds to immature MUC5AC in the 313 endoplasmic reticulum, where it is thought to play a role in mucin folding. AGR2 deficient 314 mice have profound defects in intestinal mucus production and reduced mucus production 315 in the airways of allergen challenged mice (36, 37). Upregulation of ERRB2 networks may 316 therefore influence asthma by modulating epithelial differentiation and mucus production. 317
318
The third hub E-cadherin (CDH1) is a cell adhesion molecule that forms adherence junctions 319 between adjacent airway epithelial cells and maintains epithelial barrier integrity (38). HDM 320 disrupts epithelial barrier function by delocalizing E-cadherin and other junction molecules, 321 and this is thought to enhance allergic sensitization and inflammation (39). Polymorphisms 322 in CDH1 are associated with airways remodeling and lung function decline, but only in those 323 asthma patients using corticosteroids (40). Dysregulation of CDH1 signaling networks may 324 impact on barrier function, inflammation, and airways remodeling. 325
326
The fourth hub IL-13 plays a central role in the pathogenesis of asthma by driving mucus 327 production, airways hyper-responsiveness, and airways remodeling (26). It is produced by 328 Th2 and group 2 innate lymphoid cells (ILC2), and it can also be produced by macrophages 329 (41, 42). IL-13 itself was not differentially expressed in HDM S wheezers versus nonwheezers, 330 however network analysis demonstrated that in the wheezers it was connected to an 331 extensive set of genes that have established roles in mouse models of allergic asthma. For 332 instance, IL-33 stimulates the production of IL-5 and IL-13 by type 2 innate lymphoid cells 333 and Th2 cells (43, 44), and in the presence of GM-CSF it can drive allergic inflammation at 334 sub-threshold allergen doses (45). In animal models, deficiency of multiple genes from the 335 IL-13 network can impact on asthma-related traits, including allergic sensitization and/or 336 inflammation (ALOX15 (46), CYBB (47)), and airways hyperresponsiveness and mucus 337 production/goblet cell hyperplasia (POSTN (48), SERPINB3/4 (49)). Moreover, transgenic 338 expression of SPDEF or FOXA3 leads to upregulation of pulmonary Th2 cytokines and 339 increased goblet cell differentiation, eosinophilic inflammation, and airway 340 hyperresponsiveness (50). It is noteworthy, that whilst both IL-13 and EGFR ligands can 341 induce the transcription of mucin genes, microarray profiling studies have shown that these 342 pathways have largely independent effects on gene regulation in bronchial epithelial cells, 343 and they play distinct roles in goblet cell metaplasia (36, 51, 52) . Many other pathways were 344 also identified that are regulated by IL-13 and relevant to asthma pathogenesis (e.g. CCL17, 345 CCL26, CTGF, FCER1A, KITLG, MUC2, NOS2, TLR3, see Table E5 ). 346
347
The second coexpression module we identified comprised genes expressed in ciliated 348 epithelial cells that control mucociliary clearance. The primary function of cilia is to beat in a 349 synchronous manner to clear mucus from the airways and into the pharynx. Thomas et al. 350 reported that cilia beat frequency was decreased in patients with asthma, and severe 351 asthmatics had abnormal ciliary orientation and microtubule defects (53). Notably, 352 employing network analysis we showed that CDHR3 was a highly ranked coexpression hub This exploratory study has limitations including small sample size that should be 363 acknowledged. The molecular profiling studies were based on a heterogeneous cell 364 population, and the pathways we identified were mainly associated with airway epithelial 365 cells, which represent a minority population in sputum. We cannot exclude the possibility 366 that epithelial shedding may have varied across the study groups and impacted on the 367 analysis, although the RUV adjustment we employed should minimize any potential 368 confounding by biological and/or technical variations. It is additionally noteworthy that 369 using prior knowledge to reconstruct gene networks relies on data derived from 370 experimental settings that may be far removed from the current study, which means that 371 conclusions drawn from these analyses may be oversimplified given that genes can function 372 in a context specific manner. Detailed follow-up mechanistic will therefore be required to 373 elucidate the specific cellular mechanisms involved, and dissect the role of the molecular 374 pathways we have identified. 375
Notwithstanding these caveats, our findings collectively are consistent with the general 377 hypothesis that progression from subclinical responsiveness to aeroallergen exposure in 378 atopic asthmatics to expression of the persistent wheezing phenotype involves the 379 establishment of coexpression networks linking Th2 effector cytokine genes in immune cells 380 recruited to the airway surface with genes expressed in adjacent epithelial cells that have 381 been implicated in myriad asthma-relevant functions including mucosal barrier integrity, 382 mucus production, tissue remodeling, responsiveness to irritants, and (exemplified by IL-33) 383 intensification of aeroallergen-specific Th2 immunity. Targeting drug development programs 384 specifically at these chronic mechanisms, as opposed to simply those that are triggered 385 during acute exacerbation events, may provide improved therapeutics for prevention of 386 asthma progression in atopics who represent the segment of the population at greatest risk 387 of this disease. 388
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